Crinetics Pharmaceuticals (CRNX) FCF Margin Growth (3y) (2020 - 2026)
Crinetics Pharmaceuticals (CRNX) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 471.36 Bn | 466.57 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 123.47 Bn | 116.22 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.52 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 8 | Argenx Se | 56.08 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 6,066.00 |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn | 35,441.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,441.00 |
| Dec 31, 2025 | 325,753.00 |
| Sep 30, 2025 | -6.57 Mn |
| Jun 30, 2025 | -236,058.00 |
| Mar 31, 2025 | -2.41 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | -57,298.00 |
| Sep 30, 2022 | -599,092.00 |
| Mar 31, 2022 | 141,372.00 |
| Dec 31, 2021 | -132,038.00 |
| Dec 31, 2020 | 2.30 Mn |